Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Revolution Medicines (RVMD) reported Depreciation & Amortization (CF) of $2.45 million for Q2 2026, up 6.8% from $2.29 million a year earlier and up 4.4% from the prior quarter.

Analysis

Revolution Medicines (RVMD) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Revolution Medicines' Depreciation & Amortization (CF) came in at $8.59 million, up 16.7% year-over-year; for FY2025, it was $7.78 million, up 18.6% from FY2024.

  • Depreciation & Amortization (CF) has increased for seven consecutive years, with a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $6.56 million in FY2024 (+30.1%), $5.04 million in FY2023 (+26.9%), $3.97 million in FY2022 (+28.1%) and $3.1 million in FY2021 (+18.7%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2019.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last three quarters, with growth averaging 22.3% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2025 (growth of 39.6%); the low point was Q3 2025 (a decline of 6.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.35 million (Q1 2026), $2.27 million (Q4 2025) and $1.53 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 1.96 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 194.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.93 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 98.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 1.62 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn - 2.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.45 Mn
Mar 31, 2026 2.35 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 2.29 Mn
Mar 31, 2025 1.69 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 1.64 Mn
Jun 30, 2024 1.64 Mn
Mar 31, 2024 1.54 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.30 Mn
Jun 30, 2023 1.22 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 1.15 Mn
Sep 30, 2022 991,000.00
Jun 30, 2022 931,000.00
Mar 31, 2022 901,000.00
Dec 31, 2021 833,000.00
Sep 30, 2021 793,000.00
API Access

Revolution Medicines Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RVMD&period=max&api_key=YOUR_API_KEY